Dana Mustafa

Has grant

Assistant Professor, Leader of the Spatial Biology Facility

Erasmus MC

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

About

Dana Mustafa is an Assistant Professor and the Leader of the Spatial Biology Facility at Erasmus MC in the Netherlands. His research focuses on pancreatic cancer, particularly its molecular mechanisms, immunological aspects, and the development of novel therapeutic strategies. Recent articles authored by Dr. Mustafa explore topics such as antitumor immunity, liquid biomarker signatures, and the efficacy of immunomodulatory treatments in advanced pancreatic cancer.

Recent Grants

Grant: Close

an organ-on-a-chip; a BBB model

Open Date: 2012-12-01

Close Date: 2013-06-01

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Willem de Koning

Erasmus University Rotterdam

NETHERLANDS

View details

Joachim G. Aerts

NETHERLANDS

View details

Casper Van Eijck

Erasmus University Rotterdam

NETHERLANDS

View details

Noel de Miranda

Professor

Leiden University Medical Center

NETHERLANDS

View details

Andrew Stubbs

Associate Professor

Erasmus MC

NETHERLANDS

View details

Ralf van de Laar

Erasmus University Rotterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dana Mustafa

Research Interests

Explore related searches

About

Recent Grants

Articles (14)

Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses

Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix

A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy

Overexpression of the adhesion signaling pathway is linked to short-term survival in pancreatic ductal adenocarcinoma

Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients

Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer

Rintatolimod (Ampligen<sup>®</sup>) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study

Differential Expression of <i>BOC</i>, <i>SPOCK2</i>, and <i>GJD3</i> Is Associated with Brain Metastasis of ER-Negative Breast Cancers

Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients

Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?

NanoGalaxy: Nanopore long-read sequencing data analysis in Galaxy

Collaborators (6)

Willem de Koning

Joachim G. Aerts

Casper Van Eijck

Noel de Miranda

Andrew Stubbs

Ralf van de Laar

Make your next move.

Dana Mustafa

Research Interests

Explore related searches

About

Recent Grants

Articles (14)

Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses

Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix

A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy

Overexpression of the adhesion signaling pathway is linked to short-term survival in pancreatic ductal adenocarcinoma

Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients

Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer

Rintatolimod (Ampligen<sup>&reg;</sup>) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study

Differential Expression of <i>BOC</i>, <i>SPOCK2</i>, and <i>GJD3</i> Is Associated with Brain Metastasis of ER-Negative Breast Cancers

Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients

Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?

NanoGalaxy: Nanopore long-read sequencing data analysis in Galaxy

Collaborators (6)

Willem de Koning

Joachim G. Aerts

Casper Van Eijck

Noel de Miranda

Andrew Stubbs

Ralf van de Laar

Make your next move.

Rintatolimod (Ampligen<sup>®</sup>) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program